Dr. Joseph Paul Alukal, MD

Dr. Alukal practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Alukal's NPI, 1003084203, was assigned on February 11, 2008. Dr. Alukal graduated from University of North Carolina at Chapel Hill School of Medicine in 2001. Dr. Alukal holds New York license 248400.

Dr. Alukal's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Alukal's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Alukal is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Alukal to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alukal practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Alukal's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Alukal is licensed in New York.

Dmand AI lists enlarged prostate, erectile dysfunction, kidney stone disease, testicular dysfunction and urinary endoscopy among the conditions Dr. Alukal treats.

CMS data shows 365 Medicare services from Dr. Alukal across 7 procedure codes in 2024, for 246 Medicare patients. Medicare paid $29,503 for them. Every service was in an office.

CMS counts 246 Medicare patients who saw Dr. Alukal in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alukal's median patient age at 54, with 1% women.

In 2024, Dr. Alukal wrote 208 Medicare Part D claims for 76 patients. 86% of them were for generic drugs. CMS names the drug for 140 of them, across 8 drugs with 11 or more claims each, at $34,332 in total drug cost. In 2023, CMS named 120 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Alukal for performance year 2024, reported through an alternative payment model (APM). Dr. Alukal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alukal as offering telehealth.

Dmand AI links 26 papers to Dr. Alukal, published from 2008 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Testis, COVID-19 and Infertility, Male. Dr. Alukal has published most often in Fertil Steril. Dr. Alukal's most frequent co-authors are Albert Sangji Ha, MD, Larry I. Lipshultz, MD and Valary T. Raup, MD.

CMS Open Payments shows 197 general payments to Dr. Alukal from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Coloplast Corp paid the most, $2,537.

Dmand AI lists 1 award for Dr. Alukal, most recently CMS Stage 1 EHR in 2013.

Dr. Alukal graduated from University of North Carolina at Chapel Hill School of Medicine in 2001.

Dr. Alukal is in network with 16 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.